1. PET Imaging Centre, Division of Imaging Sciences and Biomedical Engineering, King’s College London, King’s Health Partners, St. Thomas’ Hospital, London, United Kingdom;
2. Cancer Research UK and UCL Cancer Trials Centre, London, United Kingdom;
3. Department of Nuclear Medicine, University of Modena and Reggio Emilia, Modena, Italy;
4. Department of Molecular Imaging (PET-CT), Royal Prince Alfred Hospital, Sydney, Australia;
5. Sydney Medical School, University of Sydney, Sydney, Australia;
6. Department of Medical Imaging and Physiology and
7. Department of Oncology and Radiation Physics, Skane University Hospital, Lund University, Lund, Sweden;
8. Department of Nuclear Medicine & PET Centre, Aarhus University Hospital, Aarhus, Denmark;
9. Department of Radiology, Guy's and St. Thomas' National Health Service (NHS) Foundation Trust, London, United Kingdom;
10. Oncology Unit, Department of Diagnostic, Clinical and Public Health Medicine, University of Modena and Reggio Emilia, Modena, Italy;
11. The University of Manchester and the Christie NHS Foundation Trust, Manchester, United Kingdom;
12. Concord, Repatriation General Hospital, Sydney, Australia;
13. Department of Oncology, Norwegian Radium Hospital, Oslo, Norway;
14. Haematology, Auckland City Hospital, Auckland, New Zealand;
15. Department of Genetics and Pathology, Experimental and Clinical Oncology, Uppsala University, Uppsala, Sweden;
16. Haematology, Aarhus University, Aarhus, Denmark; and
17. Cancer Research UK Centre, University of Southampton, Southampton, United Kingdom